Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
A HeidenreichU H Engelmann

Abstract

The role of p53 in testicular germ cell tumours is still contradictory based on the finding of immunohistochemical overexpression at the protein level, but lack of mutations at the DNA level. In addition, p53 wild-type activity has been demonstrated in cell culture experiments. Overexpression of the proto-oncogene bcl-2 might block p53-induced apoptosis and might inhibit p53 functional activity. To clarify the apparent paradox with respect to p53 overexpression and lack of mutations, an immunohistochemical and mutational analysis of p53 and bcl-2 in TGCT was performed. Ten normal testes, 52 CIS and 151 clinical stage I nonseminomatous GCTs were included in our study. A commercially available anti-p53 polyclonal rabbit antibody and an anti-bcl-2-mouse monoclonal antibody were used to stain the 5pm sections. Staining was assessed by counting at least 500 cells from the area of the most intense staining in each tumour cell type, and this was scored semiquantitatively for intensity of staining on a 4 point scale. In addition, 30 primary GCTs were included in the mutational analysis: areas with p53 overexpression were identified and microdissected prior to DNA extraction. p53 exons 5-8 were amplified by polymerase chain reaction (PC...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·U M MollA J Levine
Apr 1, 1992·International Journal of Cancer. Journal International Du Cancer·H M MartinF Silvestre
Jan 1, 1992·The Prostate·J W MoulE H Chang
Sep 9, 1991·International Journal of Cancer. Journal International Du Cancer·J BártkováD P Lane
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N R RodriguesD P Lane
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D M HockenberyS J Korsmeyer
Jul 5, 1991·Science·M HollsteinC C Harris
Oct 1, 1990·International Journal of Andrology·H TeschD L Bronson
Mar 1, 1989·The Journal of Pathology·F M van den BergJ M Walboomers
Feb 15, 1988·International Journal of Cancer. Journal International Du Cancer·G CattorettiD Delia
Oct 1, 1995·The Journal of Pathology·S X JiangT Kameya
Mar 1, 1993·Developmental Biology·E AlmonV Rotter
Feb 1, 1993·Genes, Chromosomes & Cancer·K HeimdalA L Børresen
Apr 1, 1994·Journal of Cellular Biochemistry·K W KohnP M O'Connor
Jul 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G P Zambetti, A J Levine
Oct 28, 1993·The New England Journal of Medicine·C C Harris, M Hollstein
Jan 1, 1995·European Urology·A HeidenrichU H Engelmann

❮ Previous
Next ❯

Citations

May 4, 1999·International Journal of Cancer. Journal International Du Cancer·H BurgerG Stoter
May 1, 2004·Urological Research·Hans Ulrich SchmelzChristoph Sparwasser
Nov 25, 2003·Seizure : the Journal of the British Epilepsy Association·Line Sveberg RøsteLeif Gjerstad
Oct 29, 1998·Molecular Medicine Today·S G Lutzker, N J Barnard
Oct 1, 2013·Expert Reviews in Molecular Medicine·R KosterS de Jong
May 20, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Rolf I Skotheim, Ragnhild A Lothe
Apr 23, 2005·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Arthur ChiuShawn Gerstenberger
Apr 17, 2004·Pathology International·Shinji NaitoIchiro Sekine
Sep 3, 2010·The Journal of Clinical Investigation·Roelof KosterSteven de Jong
Jun 22, 2005·Virchows Archiv : an International Journal of Pathology·Finn Edler von EybenRolf Inge Skotheim
Dec 11, 2002·Chest Surgery Clinics of North America·Jane Houldsworth
Dec 11, 2002·Chest Surgery Clinics of North America·Alessia C Donadio, George J Bosl
Oct 6, 2000·The American Journal of Pathology·H RoelofsL H Looijenga
Nov 28, 2015·Surgical Pathology Clinics·Brooke E Howitt, Daniel M Berney
Nov 5, 2013·Critical Reviews in Oncology/hematology·Ludmila BoublikovaJan Trka
Jan 17, 2002·Seizure : the Journal of the British Epilepsy Association·L Sveberg RøsteL Gjerstad
Jan 23, 2015·Nature Communications·Kevin LitchfieldClare Turnbull
Jun 15, 2016·Nature Reviews. Urology·Kevin LitchfieldClare Turnbull
Sep 2, 2016·Current Opinion in Urology·Solomon L WolduAditya Bagrodia
Sep 5, 1998·The Urologic Clinics of North America·R C Dean, J W Moul
Mar 22, 2019·Andrology·J T LafinJ F Amatruda
Aug 31, 2002·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Pimlak CharoenkwanPaul S Thorner
Jan 6, 2001·Scandinavian Journal of Urology and Nephrology. Supplementum·M RørthN E Skakkebaek
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·K P Dieckmann, N E Skakkebaek
Mar 20, 2002·Archives of Pathology & Laboratory Medicine·Dinesh RakhejaJorge Albores-Saavedra

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis